Educational CME Accredited Programme

Implementing guidelines: a patient-centered approach for daily practice

  • Why and in whom is combination needed?  

          Luis Masana, Barcelona, Spain

  • Difficult cases to reach goal:
    • FH
      Meral Kayikcioglu, Izmir, Turkey
    • Recurrent event on statin
      Michel Farnier, Dijon, France
  • Can combination aid adherence ?  (fixed dose, intolerance) 
    Michal Vrablik, Prague, Czech Republic
  • How are guidelines implemented in real life?
    Guy de Backer, Ghent, Belgium


The role of TG-rich lipoproteins in atherosclerosis

  • TG-rich lipoproteins as a risk factor 
    Ruth Frikke-Schmidt, Copenhagen, Denmark
  • The value of omega 3: from biology to clinical practice
    Alberto Zambon, Padova, Italy
  • Position of omega 3 in Guidelines (as second choice after statins)
    Christie Ballantyne, Houston, USA
  • Case:  Diabetic patient with MI – how to manage?
    Dirk Mueller, Köln, Germany

Novel approaches to lipid lowering management

  • What is the landscape on lipid management today?
    Lale Tokgozoglu, Turkey
  • When do we need add on therapies to statin?
    Ulrich Laufs, Germany
  • What do we know so far about bempedoic acid?
    Kausik Ray, UK